Načítá se...
Duration of intravenous antibiotic therapy in people with cystic fibrosis
BACKGROUND: Progressive lung damage from recurrent exacerbations is the major cause of mortality and morbidity in cystic fibrosis. Life expectancy of people with cystic fibrosis has increased dramatically in the last 40 years. One of the major reasons for this increase is the mounting use of antibio...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2019
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6728060/ https://ncbi.nlm.nih.gov/pubmed/31487382 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD006682.pub6 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|